BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 36103974)

  • 1. Novel thiazolidinedione analog reduces a negative impact on bone and mesenchymal stem cell properties in obese mice compared to classical thiazolidinediones.
    Benova A; Ferencakova M; Bardova K; Funda J; Prochazka J; Spoutil F; Cajka T; Dzubanova M; Balcaen T; Kerckhofs G; Willekens W; van Lenthe GH; Alquicer G; Pecinova A; Mracek T; Horakova O; Rossmeisl M; Kopecky J; Tencerova M
    Mol Metab; 2022 Nov; 65():101598. PubMed ID: 36103974
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin sensitizer MSDC-0602K in non-alcoholic steatohepatitis: A randomized, double-blind, placebo-controlled phase IIb study.
    Harrison SA; Alkhouri N; Davison BA; Sanyal A; Edwards C; Colca JR; Lee BH; Loomba R; Cusi K; Kolterman O; Cotter G; Dittrich HC
    J Hepatol; 2020 Apr; 72(4):613-626. PubMed ID: 31697972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel insulin sensitizer MSDC-0602K improves insulinemia and fatty liver disease in mice, alone and in combination with liraglutide.
    Kamm DR; Pyles KD; Sharpe MC; Healy LN; Colca JR; McCommis KS
    J Biol Chem; 2021; 296():100807. PubMed ID: 34022222
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Additive Effects of Omega-3 Fatty Acids and Thiazolidinediones in Mice Fed a High-Fat Diet: Triacylglycerol/Fatty Acid Cycling in Adipose Tissue.
    Bardova K; Funda J; Pohl R; Cajka T; Hensler M; Kuda O; Janovska P; Adamcova K; Irodenko I; Lenkova L; Zouhar P; Horakova O; Flachs P; Rossmeisl M; Colca J; Kopecky J
    Nutrients; 2020 Dec; 12(12):. PubMed ID: 33291653
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The beneficial metabolic effects of insulin sensitizers are not attenuated by mitochondrial pyruvate carrier 2 hypomorphism.
    Vigueira PA; McCommis KS; Hodges WT; Schweitzer GG; Cole SL; Oonthonpan L; Taylor EB; McDonald WG; Kletzien RF; Colca JR; Finck BN
    Exp Physiol; 2017 Aug; 102(8):985-999. PubMed ID: 28597936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insulin resistance and metabolic derangements in obese mice are ameliorated by a novel peroxisome proliferator-activated receptor γ-sparing thiazolidinedione.
    Chen Z; Vigueira PA; Chambers KT; Hall AM; Mitra MS; Qi N; McDonald WG; Colca JR; Kletzien RF; Finck BN
    J Biol Chem; 2012 Jul; 287(28):23537-48. PubMed ID: 22621923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An insulin-sensitizing thiazolidinedione, which minimally activates PPARγ, does not cause bone loss.
    Fukunaga T; Zou W; Rohatgi N; Colca JR; Teitelbaum SL
    J Bone Miner Res; 2015 Mar; 30(3):481-8. PubMed ID: 25257948
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA miR-222 mediates pioglitazone beneficial effects on skeletal muscle of diet-induced obese mice.
    de Mendonça M; de Sousa É; da Paixão AO; Araújo Dos Santos B; Roveratti Spagnol A; Murata GM; Araújo HN; Imamura de Lima T; Passos Simões Fróes Guimarães DS; Silveira LR; Rodrigues AC
    Mol Cell Endocrinol; 2020 Feb; 501():110661. PubMed ID: 31770568
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effects of thiazolidinediones on human bone marrow stromal cell differentiation in vitro and in thiazolidinedione-treated patients with type 2 diabetes.
    Beck GR; Khazai NB; Bouloux GF; Camalier CE; Lin Y; Garneys LM; Siqueira J; Peng L; Pasquel F; Umpierrez D; Smiley D; Umpierrez GE
    Transl Res; 2013 Mar; 161(3):145-55. PubMed ID: 23022285
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MSDC-0602K, a metabolic modulator directed at the core pathology of non-alcoholic steatohepatitis.
    Colca JR; McDonald WG; Adams WJ
    Expert Opin Investig Drugs; 2018 Jul; 27(7):631-636. PubMed ID: 29950116
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel peroxisome proliferator-activated receptor gamma ligand improves insulin sensitivity and promotes browning of white adipose tissue in obese mice.
    Wu D; Eeda V; Undi RB; Mann S; Stout M; Lim HY; Wang W
    Mol Metab; 2021 Dec; 54():101363. PubMed ID: 34710641
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Obesity-Associated Hypermetabolism and Accelerated Senescence of Bone Marrow Stromal Stem Cells Suggest a Potential Mechanism for Bone Fragility.
    Tencerova M; Frost M; Figeac F; Nielsen TK; Ali D; Lauterlein JL; Andersen TL; Haakonsson AK; Rauch A; Madsen JS; Ejersted C; Højlund K; Kassem M
    Cell Rep; 2019 May; 27(7):2050-2062.e6. PubMed ID: 31091445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pretreatment of human mesenchymal stem cells with pioglitazone improved efficiency of cardiomyogenic transdifferentiation and cardiac function.
    Shinmura D; Togashi I; Miyoshi S; Nishiyama N; Hida N; Tsuji H; Tsuruta H; Segawa K; Tsukada Y; Ogawa S; Umezawa A
    Stem Cells; 2011 Feb; 29(2):357-66. PubMed ID: 21732492
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of KY-903, a Novel Tetrazole-Based Peroxisome Proliferator-Activated Receptor γ Modulator, in Male Diabetic Mice and Female Ovariectomized Rats.
    Ito Y; Yamamoto M; Furukawa S; Fukui M; Morishita K; Kitao T; Shirahase H
    Biol Pharm Bull; 2021; 44(5):659-668. PubMed ID: 33952822
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism by which a novel non-thiazolidinedione peroxisome proliferator-activated receptor gamma agonist, FK614, ameliorates insulin resistance in Zucker fatty rats.
    Minoura H; Takeshita S; Kimura C; Hirosumi J; Takakura S; Kawamura I; Seki J; Manda T; Mutoh S
    Diabetes Obes Metab; 2007 May; 9(3):369-78. PubMed ID: 17391165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The extracellular matrix of human bone marrow adipocytes and glucose concentration differentially alter mineralization quality without impairing osteoblastogenesis.
    Entz L; Falgayrac G; Chauveau C; Pasquier G; Lucas S
    Bone Rep; 2022 Dec; 17():101622. PubMed ID: 36187598
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitochondrial Dysfunction in Diabetic Cardiomyopathy: Effect of Mesenchymal Stem Cell with PPAR-γ Agonist or Exendin-4.
    Wassef MAE; Tork OM; Rashed LA; Ibrahim W; Morsi H; Rabie DMM
    Exp Clin Endocrinol Diabetes; 2018 Jan; 126(1):27-38. PubMed ID: 28449155
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Obesity enhances the recruitment of mesenchymal stem cells to visceral adipose tissue.
    de Assis-Ferreira A; Saldanha-Gama R; de Brito NM; Renovato-Martins M; Simões RL; Barja-Fidalgo C; Vargas da Silva S
    J Mol Endocrinol; 2021 Jun; 67(1):15-26. PubMed ID: 34045365
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pioglitazone-induced increase of insulin sensitivity in the muscles of the obese Zucker fa/fa rat cannot be explained by local adipocyte differentiation.
    Hallakou S; Foufelle F; Doaré L; Kergoat M; Ferré P
    Diabetologia; 1998 Aug; 41(8):963-8. PubMed ID: 9726600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells.
    Aaron N; Kraakman MJ; Zhou Q; Liu Q; Costa S; Yang J; Liu L; Yu L; Wang L; He Y; Fan L; Hirakawa H; Ding L; Lo J; Wang W; Zhao B; Guo E; Sun L; Rosen CJ; Qiang L
    Elife; 2021 Jun; 10():. PubMed ID: 34155972
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.